Title: President, Chief Executive Officer
Location: Andover, Massachusetts, United States
Kevin H. Dykstra, PhD, FCP, President and Chief Executive Officer at qPharmetra, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in the pharmaceutical industry.
With more than 20 years of professional experience, Dr. Dykstra has served as the president and chief executive officer of qPharmetra since 2010. In this position, he leads a team of industry experts with specialties in drug modeling to aid in the development of more effective medicine in such areas as oncology, endocrinology, gastrointestinal disorders, hematology, and immunology. In addition, qPharmetra utilizes the science of pharmacometrics, a cutting edge science that quantifies information regarding drugs and disease to help in the drug development progress and regulation.
Prior to this engagement, Dr. Dykstra was the senior vice president of strategic consulting and lead scientist of Certara LP, formerly known as Pharsight Corporation, from 2007 to 2010. Previously, he served Certara LP as a lead and senior scientist since 2000, as well as acting as the associate director of clinical pharmacology at Wyeth Pharmaceuticals and a biostatistician with the Genetics Institute.
Delving into his profession due to an interest in biochemical engineering, Dr. Dykstra is backed by an extensive education, first earning a Bachelor of Arts in chemical engineering and second Bachelor of Science in German from the University of Colorado Boulder in 1983. From 1984 to 1989, he completed coursework in biostatistics from Boston University and subsequently obtained a Master of Science in biochemical and biomedical engineering from the University of Michigan in 1985. In 1989, Dr. Dykstra earned a Doctor of Philosophy in biochemical and biomedical engineering from the University of Michigan, and he completed a postdoctoral fellowship with the National Institutes of Health from 1989 to 1992.
A contributor of articles to peer-reviewed journals, Dr. Dykstra aided in the publication of “Reporting Guidelines for Population.” Notably, he is a fellow of the American College of Clinical Pharmacology. Married with three children, he enjoys playing piano, bicycling, road riding, and mountain biking in his spare time. Looking toward the future, he aspires to continue experiencing the growth and success of his career.
Contact Dr. Dykstra